General Information of the Compound
| Compound ID |
CP0016034
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
8-[(3-Bromophenyl)amino]-3-methyl-3H-imidazo[4,5-g]-quinazoline
Show/Hide
|
||||||||||||||||||
| Synonyms |
174709-30-9
8-[(3-Bromophenyl)amino]-3-methyl-3H-imidazo[4,5-g]-quinazoline
AC1L1DNH
ACM174709309
AKOS025394452
BDBM3574
BPIQ-I
BRD-K72211743-001-01-1
CCG-206740
CHEMBL174426
CTK8E6742
DTXSID60274366
GTPL5939
HMS3229C05
HSCI1_000090
IN1402
Imidazoquinazoline deriv. 12
J-011030
MolPort-044-561-412
N-(3-bromophenyl)-3-methyl-3H-imidazo[4,5-g]quinazolin-8-amine
RT-011807
SCHEMBL17931472
ZINC2391775
bpiq-i
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H12BrN5
|
||||||||||||||||||
| Molecular Weight |
354.211
|
||||||||||||||||||
| Canonical SMILES |
Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H12BrN5/c1-22-9-20-14-6-12-13(7-15(14)22)18-8-19-16(12)21-11-4-2-3-10(17)5-11/h2-9H,1H3,(H,18,19,21)
Show/Hide
|
||||||||||||||||||
| InChIKey |
YAMAGACQNDAKFB-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound